Literature DB >> 12065542

Analogous cytokine responses to Burkholderia pseudomallei strains contrasting in virulence correlate with partial cross-protection in immunized mice.

Glen C Ulett1, Natkunam Ketheesan, Timothy W Clair, Catriona L McElnea, Jodie L Barnes, Robert G Hirst.   

Abstract

Cytokine mRNA levels were assessed in Burkholderia pseudomallei-susceptible BALB/c mice and B. pseudomallei-resistant C57BL/6 mice following administration of a sublethal dose of less virulent (LV) B. pseudomallei, a candidate immunogen tested for protection against a highly virulent (HV) challenge. Compared on the basis of the bacterial loads, the cytokine patterns induced by HV and LV B. pseudomallei were similar, involving gamma interferon, interleukin-10, and other cytokines. Partial cross-protection between B. pseudomallei strains is shown to be associated with cytokine profiles involving both type 1 and type 2 cytokines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065542      PMCID: PMC128107          DOI: 10.1128/IAI.70.7.3953-3958.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  High efficiency transformation of Escherichia coli with plasmids.

Authors:  H Inoue; H Nojima; H Okayama
Journal:  Gene       Date:  1990-11-30       Impact factor: 3.688

2.  CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia.

Authors:  W C Tsai; R M Strieter; B Mehrad; M W Newstead; X Zeng; T J Standiford
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand.

Authors:  W Chaowagul; N J White; D A Dance; Y Wattanagoon; P Naigowit; T M Davis; S Looareesuwan; N Pitakwatchara
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

4.  Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes.

Authors:  E Caron; T Peyrard; S Köhler; S Cabane; J P Liautard; J Dornand
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble interleukin-2 receptors without change in soluble CD8 protein.

Authors:  A E Brown; D A Dance; Y Suputtamongkol; W Chaowagul; S Kongchareon; H K Webster; N J White
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

6.  Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.

Authors:  G S Nabors; R L Tarleton
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

7.  Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity.

Authors:  S Ehlers; M E Mielke; T Blankenstein; H Hahn
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

8.  Cytokine expression in vivo during murine listeriosis. Infection with live, virulent bacteria is required for monokine and lymphokine messenger RNA accumulation in the spleen.

Authors:  R M Poston; R J Kurlander
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

9.  Tumor necrosis factor in septicemic melioidosis.

Authors:  Y Suputtamongkol; D Kwiatkowski; D A Dance; W Chaowagul; N J White
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

10.  Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection.

Authors:  J S Friedland; Y Suputtamongkol; D G Remick; W Chaowagul; R M Strieter; S L Kunkel; N J White; G E Griffin
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

View more
  7 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.

Authors:  Samantha J Dando; Deepak S Ipe; Michael Batzloff; Matthew J Sullivan; David K Crossman; Michael Crowley; Emily Strong; Stephanie Kyan; Sophie Y Leclercq; Jenny A K Ekberg; James St John; Ifor R Beacham; Glen C Ulett
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

3.  Evaluation of surrogate animal models of melioidosis.

Authors:  Jonathan Mark Warawa
Journal:  Front Microbiol       Date:  2010-12-29       Impact factor: 5.640

4.  Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione.

Authors:  Chidchamai Kewcharoenwong; Darawan Rinchai; Arnone Nithichanon; Gregory J Bancroft; Manabu Ato; Ganjana Lertmemongkolchai
Journal:  Sci Rep       Date:  2016-10-07       Impact factor: 4.379

5.  Host gene expression analysis in Sri Lankan melioidosis patients.

Authors:  Shivankari Krishnananthasivam; Nimanthi Jayathilaka; Harindra Darshana Sathkumara; Enoka Corea; Mohan Natesan; Aruna Dharshan De Silva
Journal:  PLoS Negl Trop Dis       Date:  2017-06-19

6.  Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei.

Authors:  Sylvia R Trevino; Christopher P Klimko; Matthew C Reed; Michael J Aponte-Cuadrado; Melissa Hunter; Jennifer L Shoe; Joshua R Meyer; Jennifer L Dankmeyer; Sergei S Biryukov; Avery V Quirk; Kristen A Fritts; Steven J Kern; David P Fetterer; Lara J Kohler; Ronald G Toothman; Joel A Bozue; Christopher W Schellhase; Norman Kreiselmeier; Sharon P Daye; Susan L Welkos; Carl Soffler; Patricia L Worsham; David M Waag; Kei Amemiya; Christopher K Cote
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

7.  Gene Expression Profile of Human Cytokines in Response to Burkholderia pseudomallei Infection.

Authors:  Shivankari Krishnananthasivam; Harindra Darshana Sathkumara; Enoka Corea; Mohan Natesan; Aruna Dharshan De Silva
Journal:  mSphere       Date:  2017-04-19       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.